| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel. | Mol Cancer Ther | 2010 | 1.48 |
| 2 | Potent anti-tumor activity of a macrocycle-quinoxalinone class pan-Cdk inhibitor in vitro and in vivo. | Invest New Drugs | 2010 | 0.78 |
| 3 | Biological characterization of 2-aminothiazole-derived Cdk4/6 selective inhibitor in vitro and in vivo. | Cell Cycle | 2010 | 0.76 |